Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check3 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6 label. This reflects an update to the study page's revision metadata rather than substantive content changes.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a new version of the page. This change is confined to metadata and does not alter the displayed content or behavior.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the entry. There is no change to the study details or data.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page shows a new revision tag (v3.6.4) replacing the previous tag (v3.6.3), reflecting a minor update to the page's versioning metadata.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page revision stamp was updated from v3.6.0 to v3.6.3, indicating a newer version of the study record. This update is a metadata change and does not modify the study details or how the page functions.SummaryDifference0.1%

- Check96 days agoChange DetectedA recruitment status notice indicates the study is no longer enrolling participants. New guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention/Treatment' heading formatting was updated alongside a revision note to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.